Comparison of bullying victimization and depression symptoms among Chinese adolescents before and after the end of the dynamic zero-COVID-19 policy: a repeated cross-sectional study.

Publication date: Feb 03, 2025

The COVID-19 pandemic has had a significant impact on the physical and mental health of human beings. Most adolescents in mainland of China have been infected with COVID-19 after the adjustment of the dynamic zero-COVID-19 policy. This study aims to analyze the relationship between the COVID-19 pandemic effect and depressive symptoms among adolescents in mainland China. This school-based repeated cross-sectional study was conducted on students aged 11-19 years from September to October 2022 and September to October 2023 in Ningbo, Zhejiang Province, China, using a stratified cluster, multistage sampling method. Data analysis occurred from January to June 2024. Depression symptoms and bullying victimization, exclusion of cyberbullying, were assessed using the 20-item Center for Epidemiological Studies Depression Scale (CES-D) and Bully/Victim Questionnaire, respectively. In the first survey wave in 2022 during the dynamic zero-COVID-19 policy period in Mainland China, 10,224 participants completed the questionnaires. In wave 2 survey in 2023 which was the first year after lifting of the dynamic zero-COVID-19 policy, 11,604 participants completed the questionnaires. This resulted in a sample of 10,224 in wave 1 and 11,604 in wave 2. The mean age in wave 1 was 15. 2 (SD = 1. 7) and 15. 1 (SD = 1. 8) in wave 2. The prevalence of depression symptoms in adolescents in wave 2 was higher than in wave 1 (17. 0% vs. 14. 6%, P 

Open Access PDF

Concepts Keywords
China Adolescents
Cyberbullying Bullying
Epidemiological COVID-19
January Cross-sectional studies
June Depression

Semantics

Type Source Name
disease MESH bullying
disease MESH depression
disease MESH COVID-19
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH emergency
disease MESH infection
drug DRUGBANK Etoperidone
disease IDO nucleic acid
drug DRUGBANK Cysteamine
disease IDO contact tracing
disease MESH infectious diseases
drug DRUGBANK Indoleacetic acid
disease MESH lifestyle
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH suicide

Original Article

(Visited 2 times, 1 visits today)